Dr Margaret O'Hara, from the
Molecular Physics Group and primary investigator on the project, said: «Previous
studies have found potential biomarkers for liver disease, such as isoprene and acetone, but they are not specific enough because they are possible biomarkers for other diseases or can arise from
numerous normal metabolic processes.